Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cannabix Technologies Inc C.BLO

Alternate Symbol(s):  BLOZF

Cannabix Technologies Inc. is a Canada-based developer of marijuana and alcohol breathalyzer technologies for law enforcement, workplaces and laboratories. The Company is working to develop delta-9 tetrahydrocannabinol (THC) and alcohol screening devices. Delta-9 THC is the psychoactive component of marijuana. Breath testing for delta-9 THC would allow employers and law enforcement to identify recent marijuana use. It develops contactless breath alcohol detection devices. Its technologies include THC Breathalyzer System, Breath Logix Alcohol Breathalyzer and Breath Logix Vehicle. THC Breathalyzer System includes Cannabix Mass Spectrum (MS) Breath Sampler (MSBS) and Cannabix Breath Collection Unit (BCU). The Breath Logix (BR-LGX) Industrial Series is a fully automated breath alcohol screening system for employee, contractor and visitor access control. The BR-LGX vehicle device could be integrated into various locations in the vehicle cabin. It also develops Cannabix FAIMS device.


CSE:BLO - Post by User

Post by DownSouthon Oct 04, 2023 12:27am
264 Views
Post# 35668283

Now I’m worried

Now I’m worried

This comment made in todays announcement makes me worried.

'

"Readers should note, although the Company has achieved proof of concept prototype for its BCU and MS Breath Sampler (“technology”), the testing method and technology are still in the preapproval stage and accordingly the Company is not currently making any express or implied claims that the technology will proceed to commercial use. Furthermore, the method and technology used to quantify delta-9 THC in breath samples are in the preliminary testing phase and will require additional validation."

<< Previous
Bullboard Posts
Next >>